Screener
Zevra Therapeutics, Inc. ZVRA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s asset turnover?
- Zevra Therapeutics, Inc. (ZVRA) reported asset turnover of 0.5× in Q2 2026.
- How has Zevra Therapeutics, Inc.'s asset turnover changed year-over-year?
- Zevra Therapeutics, Inc.'s asset turnover increased by 57.2% year-over-year, from 0.3× to 0.5×.
- What is the long-term trend for Zevra Therapeutics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s asset turnover has grown at a -17.8% compound annual growth rate (CAGR), from 1.2× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Zevra Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude